Thursday, July 30, 2026 2:38 AM ET
12 hours ago
Humana tops estimates, maintains profit outlook as medical costs stay in line12 hours ago
Why shareholders are suing Novo Nordisk over next-generation weight-loss drug17 hours ago
Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead1 day ago
Kentucky Gov. Beshear calls on Mitch McConnell to prove he can serve or resign1 day ago
McConnell still not cleared to go back to work as he recovers from fall: Doctors1 day ago
Consolidated food supply may be worsening cyclospora outbreaks, experts say2 days ago
FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business2 days ago
Here are 4 forces that drove a tough week for stocks4 days ago
CDC says massive cyclospora outbreak is now in nine states5 days ago
Cyclospora outbreak tests RFK Jr.'s promise to overhaul food system5 days ago
Eli Lilly says it will file for approval of next-generation obesity drug in 20276 days ago
Ozempic face? Botox boom boosted by 'sagging face' trend, Swiss firm says6 days ago
What Trump's generic drug tariffs could mean for patients, drugmakers and prices6 days ago
RFK Jr. says cyclospora outbreak is 'under control'8 days ago
Cardinal Health's latest deals won't move the needle overnight. They still matter.8 days ago
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising8 days ago
The FDA made a reversal on cyclosporiasis, but it still thinks iceberg lettuce is to blame8 days ago
What to know about testosterone replacement as U.S. military plans to test troops9 days ago
Market case for psychedelic drugs to treat mental health gets a big buy signal9 days ago
Fat cat? Weight-loss drugs may be coming for your overweight pet12 days ago
Trump rips Canada for wildfire smoke, threatens to raise tariffs12 days ago
Taco Bell says it has removed lettuce linked to cyclosporiasis outbreak from its restaurants12 days ago
World's largest olive oil company says market has 'definitively' entered new phase13 days ago
Buy the contractor before the renovation is complete: This stock's next growth phase is taking shape13 days ago
3 of our stocks rode the AI rally, while 3 others fell out of favor since last month13 days ago
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion13 days ago
UnitedHealth beats quarterly estimates, hikes profit outlook13 days ago
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways14 days ago
Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up15 days ago
A tiny GLP-1 implant is the latest bet to help patients maintain weight loss15 days ago
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?18 days ago